Tag: GlobeNewswire

NEW YORK and WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced the Company’s participation in five investor conferences.

• Guggenheim 3rd Annual Healthcare Innovation Conference: Marino Garcia, CEO, will participate in a fireside chat on Monday, November 9, 2026, at 11:00 a.m. ET. Marino Garcia and Ryan Savitz, EVP, CFO & CBO, will also host one-on-one investor meetings.
• Stifel 2026 Healthcare Conference: Marino Garcia will participate in a fireside chat on Wednesday, November 11, 2026, at 9:20 a.m. ET. Marino Garcia and Ryan Savitz will also host one-on-one investor meetings.
• 2026 Truist Securities BioPharma Symposium: Ryan Savitz will host one-on-one investor meetings on Thursday, November 12, 2026.
• UBS Global Biopharma Conference: Marino Garcia will participate in a fireside chat on Monday, November 16, 2026, at 9:20 a.m. GMT. Marino Garcia and Ryan Savitz will also host one-on-one investor meetings.
• Jefferies Global Healthcare Conference: Marino Garcia will participate in a fireside chat on Wednesday, November 18, 2026, at 2:30 p.m. GMT. Marino Garcia and Ryan Savitz will also host one-on-one investor meetings.

Webcasts of the fireside chats may be accessed under “News and Events” in the Investors section of the Dianthus Therapeutics website.

About Dianthus Therapeutics
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who aim to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases.

To learn more, please visit www.dianthustx.com and follow us on LinkedIn. 

Contact
Jennifer Davis Ruff
Dianthus Therapeutics
jdavisruff@dianthustx.com

VANCOUVER, BC and BOSTON, MA, Nov. 02, 2026 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced it will report its third quarter 2026 financial results and provide a business update after the close of U.S. financial markets on Monday, November 9, 2026.

Company Presentation Details:

Date:	Monday, November 9, 2026
Time:	4:30pm EST (2:30pm PCT)
Webcast:	Pre-register here
Dial-In:	(800) 715-9871 toll-free or (646) 307-1963 for international callers
Conference ID:	8984105

A live webcast of the company presentation will be available on the Investors section of Xenon’s website and posted for replay following the event. The above-mentioned dates and times are subject to change.

About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (Nasdaq: XENE) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. Xenon’s lead molecule, azetukalner, is a novel, potent K_V7 potassium channel opener in late-stage clinical development for the treatment of epilepsy, major depressive disorder and bipolar depression. Xenon is also advancing an early-stage portfolio of multiple promising potassium and sodium channel modulators, including K_V7 and Na_V1.7 programs in Phase 1 development for the potential treatment of pain. Xenon has offices in Vancouver, British Columbia, and Boston, Massachusetts. For more information, visit www.xenon-pharma.com and follow us on LinkedIn and X.

Xenon and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in the US, Canada and elsewhere. All other trademarks belong to their respective owner.

Contacts: 
For Investors:
Laura Perry/Emily Huang
Argot Partners
Xenon@argotpartners.com

For Media:
Colleen Alabiso
Senior Vice President, Corporate Affairs
media@xenon-pharma.com

DALLAS, Nov. 02, 2026 (GLOBE NEWSWIRE) — Capital Southwest Corporation (“Capital Southwest,” “CSWC” or the “Company”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, today announced its financial results for the second fiscal quarter ended September 30, 2026.

Second Quarter Fiscal Year 2027 Financial Highlights

• Total Investment Portfolio at Fair Value: $2.4 billion
  • Credit Portfolio at Fair Value of $2.2 billion
    • 99% 1st Lien Senior Secured Debt
    • $376.8 million in new committed credit investments during the quarter
    • Weighted Average Yield on Debt Investments: 10.9%
    • Current non-accruals with a fair value of $34.8 million, representing 1.4% of the total investment portfolio, and a cost basis of $85.5 million, representing 3.5% of the total investment portfolio
  • Equity Portfolio at Fair Value of $192.3 million, excluding investment in CapTrin Partners, LLC (“CapTrin”) and Desert Star 2026 LLC (“Desert Star”), CSWC’s unconsolidated joint ventures (“JV equity”)
    • $14.2 million in new equity co-investments during the quarter
  • CSWC Joint Venture (“JV”) Equity Investments at Fair Value: $36.4 million
    • Investment in CapTrin at fair value of $28.4 million
      • CapTrin portfolio at fair value of $126.7 million
    • Investment in Desert Star at fair value of $7.9 million
      • $25.0 million in new commitment to Desert Star during the quarter
      • Desert Star portfolio at fair value of $128.2 million
• Pre-Tax Net Investment Income: $37.2 million, or $0.58 per weighted average common share outstanding
• Estimated Undistributed Taxable Income (“UTI”): $0.92 per share as of September 30, 2026
• LTM Operating Leverage: 1.4% as of September 30, 2026
• Dividends: Paid Total Dividends for the quarter ended September 30, 2026 of $0.64
  • Paid $0.58 per share Regular Quarterly Dividend ($0.1934 per share in each of July, August and September 2026)
  • Paid $0.06 per share Supplemental Quarterly Dividend in September 2026
• Net Realized and Unrealized Depreciation: $13.4 million, or 0.6% of total investments at fair value
  • $1.7 million of net appreciation related to the equity portfolio
  • $14.6 million of net depreciation related to the credit portfolio
  • $0.5 million net realized and unrealized income tax provision
• Balance Sheet:
  • Cash and Cash Equivalents: $48.0 million
  • Total Net Assets: $1.1 billion
  • Net Asset Value (“NAV”) per Share: $16.64

In commenting on the Company’s results, Michael Sarner, President and Chief Executive Officer, stated, “Capital Southwest delivered the largest origination quarter in our history, with approximately $391 million of originations across 14 new and 16 existing portfolio companies. We also committed $25 million to Desert Star, a new joint venture with Trinity Capital. This new joint venture gives us access to the technology lending market in partnership with Trinity, allowing us to gain exposure through a granular portfolio of investments in an area where we have not historically focused.

Our portfolio continued to generate strong earnings for our shareholders, producing $0.58 of pre-tax net investment income per share. Reflecting the strength of our earnings profile, the Board of Directors again declared a regular quarterly dividend of $0.58 per share, of which $0.1934 per share will be paid for each of October, November and December 2026, and a supplemental quarterly dividend of $0.06 to be paid in December 2026.

We also continued to strengthen and diversify our capital base. During the quarter, we successfully raised a new $350 million unsecured bond at 6.75%, which we used to pay down our Corporate Credit Facility. We also continued to efficiently raise equity capital during the quarter, raising approximately $67 million through our Equity ATM Program. Finally, pursuant to recent legislation, we received SBA approval to increase Capital Southwest SBIC II, LP’s leverage commitment from $175 million to $250 million, further enhancing our capacity to deploy capital through SBIC II.”

Second Quarter Fiscal Year Investment Activities

During the quarter ended September 30, 2026, the Company originated $391.0 million in new commitments, consisting of investments in 14 new portfolio companies totaling $327.1 million and add-on commitments in 16 portfolio companies totaling $63.9 million. New portfolio company originations were comprised of $314.2 million in first lien senior secured debt and $12.9 million in equity investments. The Company also committed $25.0 million in equity to Desert Star.

During the quarter ended September 30, 2026, the Company received proceeds of $74.2 million from four portfolio company prepayments and exits, generating a weighted average IRR of 14.5%. Total proceeds were comprised of $69.1 million from debt investments and $5.1 million from equity investments.

Second Fiscal Quarter 2027 Operating Results

For the quarter ended September 30, 2026, Capital Southwest reported total investment income of $67.2 million, compared to $61.0 million in the prior quarter. The increase in investment income was primarily attributable to an increase in interest income due to an increase in the weighted average cost basis of investments held.

For the quarter ended September 30, 2026, total operating expenses (excluding interest expense) were $9.0 million, compared to $7.6 million in the prior quarter. The increase was primarily attributable to an increase in legal fees and proxy solicitation expenses incurred in connection with our annual meeting of shareholders, as well as an increase in employee compensation.

For the quarter ended September 30, 2026, interest expense was $21.0 million, compared to $18.5 million in the prior quarter. The increase is primarily attributable to an increase in average borrowings outstanding and an increase in the weighted average interest rate on total debt.

For the quarter ended September 30, 2026, total pre-tax net investment income was $37.2 million, compared to $35.0 million in the prior quarter.

For the quarter ended September 30, 2026, there was a tax provision of $0.9 million, compared to a tax benefit of $0.7 million in the prior quarter. The change was primarily driven by deferred tax adjustments related to the tax basis of investments held at Capital Southwest Equity Investments, Inc., our wholly owned subsidiary that has elected to be treated as a corporation for U.S. federal income tax purposes.

During the quarter ended September 30, 2026, Capital Southwest recorded total net realized and unrealized losses on investments of $13.4 million, compared to $10.9 million of total net realized and unrealized losses in the prior quarter. For the quarter ended September 30, 2026, the total net realized and unrealized losses on investments reflected net realized and unrealized appreciation on equity investments of $1.7 million, net realized and unrealized depreciation on debt investments of $14.6 million, and a net realized and unrealized income tax provision of $0.5 million. The net increase in net assets resulting from operations was $21.4 million for the quarter, compared to $24.7 million in the prior quarter.

The Company’s NAV at September 30, 2026 was $16.64 per share, compared to $16.61 per share in the prior quarter. The increase in NAV per share from the prior quarter is primarily due to the issuance of common stock at a premium to NAV per share through the Equity ATM Program (as described below), partially offset by net realized and unrealized losses on investments.

Liquidity and Capital Resources

At September 30, 2026, Capital Southwest had approximately $48.0 million in unrestricted cash and money market balances and $599.2 million of unused capacity under the Corporate Credit Facility (as defined below) and the SPV Credit Facility (as defined below). The regulatory debt to equity ratio at the end of the quarter was 1.00 to 1.

As of September 30, 2026, Capital Southwest had the following borrowings outstanding:

• $90.0 million of total debt outstanding on the Corporate Credit Facility
• $105.0 million of total debt outstanding on the SPV Credit Facility
• $225.3 million, net of amortized debt issuance costs, of the 5.125% convertible notes due November 2029
• $344.6 million, net of amortized debt issuance costs, of the 5.950% Notes due 2030
• $337.9 million, net of amortized debt issuance costs and effective hedge accounting adjustment, of the 6.750% Notes due 2031
• $281.7 million, net of unamortized debt issuance costs, of SBA Debentures (as defined below)

In August 2016, CSWC entered into a senior secured credit facility (the “Corporate Credit Facility”) to provide additional liquidity to support its investment and operational activities. Borrowings under the Corporate Credit Facility accrued interest on a per annum basis at a rate equal to the applicable SOFR rate plus 2.15%. On September 2, 2026, the Company entered into the Fourth Amended and Restated Senior Secured Revolving Credit Agreement (the “Amendment”). Borrowings under the Corporate Credit Facility accrue interest at a rate equal to the applicable Term SOFR plus 2.00% per annum. The Amendment (1) increased commitments under the Corporate Credit Facility from $510 million to $595 million from a diversified group of lenders, (2) increased the uncommitted accordion feature that could increase the maximum commitments from up to $750 million to up to $1 billion, (3) extended the revolving period from August 2, 2027 to September 2, 2030 and extended final maturity from August 2, 2028 to September 2, 2031, (4) reduced the unused commitment fees from a range of (i) 0.50%-1.00% to (ii) 0.50%-0.75% per annum, based on utilization, on the unused lender commitments; and (5) amended certain financial covenants. In connection with the Amendment, the Company recognized a realized loss on extinguishment of debt of $1.1 million during the three months ended September 30, 2026, which was equal to the write-off of the related unamortized debt issuance costs.

Capital Southwest SPV LLC (“SPV”) is a wholly owned special purpose vehicle that was formed to hold investments for the SPV Credit Facility to support our investment and operating activities. On March 20, 2024, SPV entered into a special purpose vehicle financing credit facility (the “SPV Credit Facility”). The SPV Credit Facility included an initial commitment of $150 million. Pursuant to the terms of the loan agreement, on June 20, 2024, total commitments automatically increased from $150 million to $200 million. The SPV Credit Facility also includes an accordion feature that allows increases up to $400 million of total commitments from new and existing lenders on the same terms and conditions as the existing commitments. Borrowings under the SPV Credit Facility bear interest at three-month Term SOFR plus 2.50% per annum during the revolving period ending on March 20, 2027 and three-month Term SOFR plus an applicable margin of 2.85% thereafter. SPV (i) paid unused commitment fees of 0.10% through April 20, 2024 and (ii) pays unused commitment fees of 0.35% thereafter, on the unused lender commitments under the SPV Credit Facility, in addition to other customary fees. Under the SPV Credit Facility, SPV also pays a utilization fee based on the amount of borrowings utilized. The SPV Credit Facility matures on March 20, 2029.

In September 2026, the Company issued $350 million in aggregate principal amount of 6.750% Notes due 2031 (the “September 2031 Notes”). The September 2031 Notes were issued at a price of 98.985% of the aggregate principal amount of the September 2031 Notes, resulting in yield-to-maturity of 6.994%. The September 2031 Notes mature on September 15, 2031 and may be redeemed in whole or in part at any time prior to August 15, 2031, at par plus a “make-whole” premium, and thereafter at par. The September 2031 Notes bear interest at a rate of 6.750% per year, payable semi-annually in arrears on March 15 and September 15 of each year, beginning on March 15, 2027. In connection with the September 2031 Notes, the Company has entered into an interest rate swap. Under the interest rate swap, the Company receives a fixed interest rate of 6.75% and pays a floating interest rate of Daily Compounded SOFR plus 2.1587%.

The Company has an “at-the-market” offering (the “Equity ATM Program”), pursuant to which the Company may offer and sell, from time to time through sales agents, up to $2 billion of shares of its common stock. During the quarter ended September 30, 2026, the Company sold 2,732,562 shares of its common stock under the Equity ATM Program at a weighted-average price of $24.50 per share, raising $67.0 million of gross proceeds. Net proceeds were $66.0 million after commissions to the sales agents on shares sold. As of September 30, 2026, the Company has $999.3 million available under the Equity ATM Program.

Our wholly owned subsidiaries, Capital Southwest SBIC I, LP (“SBIC I”) and Capital Southwest SBIC II, LP (“SBIC II” and together with SBIC I, the “SBIC Subsidiaries”), each received a license from the Small Business Administration (the “SBA”) to operate as a Small Business Investment Company (“SBIC”) under Section 301(c) of the Small Business Investment Act of 1958, as amended, on April 20, 2021 and April 17, 2025, respectively. The SBIC licenses allow the SBIC Subsidiaries to obtain leverage by issuing SBA-guaranteed debentures (“SBA Debentures”), subject to the issuance of a leverage commitment by the SBA. SBA Debentures are loans issued to an SBIC that have interest payable semi-annually and a ten-year maturity. The interest rate is fixed shortly after issuance at a market-driven spread over U.S. Treasury Notes with ten-year maturities. For two or more SBICs under common control, the maximum amount of outstanding SBA Debentures cannot exceed $475 million. As of September 30, 2026, SBIC I had a total leverage commitment from the SBA in the amount of $175.0 million. During the quarter ended September 30, 2026, SBIC I repaid $16.0 million of debentures, resulting in a realized loss on extinguishment of debt of $0.3 million. As of September 30, 2026, SBIC I had $159.0 million of debentures outstanding. In September 2026, SBIC II received approval from the SBA to increase its leverage commitment from $175.0 million to $250.0 million, pursuant to recent legislation. As of September 30, 2026, SBIC II had a total leverage commitment from the SBA in the amount of $175.0 million, of which $130.0 million was drawn.

Share Repurchase Program

On July 28, 2021, the Company’s Board of Directors (the “Board”) approved a share repurchase program authorizing the Company to repurchase up to $20 million of its outstanding shares of common stock in the open market at certain thresholds below its NAV per share, in accordance with guidelines specified in Rules 10b5-1(c)(1)(i)(B) and 10b-18 under the Securities Exchange Act of 1934, as amended. On August 31, 2021, the Company entered into a share repurchase agreement, which became effective immediately, and the Company will cease purchasing its common stock under the share repurchase program upon the earlier of, among other things: (1) the date on which the aggregate purchase price for all shares equals $20 million including, without limitation, all applicable fees, costs and expenses; or (2) upon written notice by the Company to the broker that the share repurchase agreement is terminated. During the quarter ended September 30, 2026, the Company did not repurchase any shares of the Company’s common stock under the share repurchase program.

Regular Quarterly Dividend of $0.58 Per Share and Supplemental Quarterly Dividend of $0.06 Per Share for Quarter Ended December 31, 2026

On August 27, 2026, the Board declared a regular quarterly dividend of $0.58, of which $0.1934 per share will be paid in each of October, November and December 2026 and a supplemental quarterly dividend of $0.06 per share payable in December 2026, each of which is detailed in the table below.

The Company’s regular quarterly dividend for the quarter ending December 31, 2026 will be payable as follows:

Declared	Ex-Dividend Date	Record Date	Payment Date	Amount Per Share
8/27/2026	10/15/2026	10/15/2026	10/30/2026	$0.1934
8/27/2026	11/13/2026	11/13/2026	11/30/2026	$0.1934
8/27/2026	12/15/2026	12/15/2026	12/31/2026	$0.1934

The Company’s supplemental quarterly dividend for the quarter ending December 31, 2026 will be payable as follows:

Declared	Ex-Dividend Date	Record Date	Payment Date	Amount Per Share
8/27/2026	12/15/2026	12/15/2026	12/31/2026	$0.06

Total Regular Dividends per Share for Quarter Ending December 31, 2026:	$0.58
Total Supplemental Dividend per Share for Quarter Ending December 31, 2026:	$0.06
Total Dividends per Share for Quarter Ending December 31, 2026:	$0.64

When declaring dividends, the Board of Directors reviews estimates of taxable income available for distribution, which may differ from net investment income under generally accepted accounting principles. The final determination of taxable income for each year, as well as the tax attributes for dividends in such year, will be made after the close of the tax year.

Capital Southwest maintains a dividend reinvestment plan (“DRIP”) that provides for the reinvestment of dividends on behalf of its registered stockholders who hold their shares with Capital Southwest’s transfer agent and registrar, Equiniti Trust Company. Under the DRIP, if the Company declares a dividend, registered stockholders who have opted into the DRIP by the dividend record date will have their dividend automatically reinvested into additional shares of Capital Southwest’s common stock. 

Second Quarter 2027 Earnings Results Conference Call and Webcast

Capital Southwest has scheduled a conference call on Tuesday, November 3, 2026, at 11:00 a.m. Eastern Time to discuss the second quarter 2027 financial results. You may access the call by using the Investor Relations section of Capital Southwest’s website at www.capitalsouthwest.com, or by using http://edge.media-server.com/mmc/p/eirjpwcv.

An audio archive of the conference call will also be available on the Investor Relations section of Capital Southwest’s website.

For a more detailed discussion of the financial and other information included in this press release, please refer to the Capital Southwest’s Quarterly Report on Form 10-Q for the fiscal year ended September 30, 2026 to be filed with the Securities and Exchange Commission (the “SEC”) and Capital Southwest’s Second Fiscal Quarter 2027 Earnings Presentation to be posted on the Investor Relations section of Capital Southwest’s website at www.capitalsouthwest.com.

About Capital Southwest

Capital Southwest Corporation (Nasdaq: CSWC) is a Dallas, Texas-based, internally managed business development company with approximately $2.4 billion in investments at fair value as of September 30, 2026. Capital Southwest is a middle market lending firm focused on supporting the acquisition and growth of middle market businesses with $5 million to $50 million investments across the capital structure, including first lien, second lien and non-control equity co-investments. As a public company with a permanent capital base, Capital Southwest has the flexibility to be creative in its financing solutions and to invest to support the growth of its portfolio companies over long periods of time.

Forward-Looking Statements

This press release contains historical information and forward-looking statements with respect to the business and investments of Capital Southwest, including, but not limited to, the statements about Capital Southwest’s future performance and financial performance and financial condition, and the timing, form and amount of any distributions or supplemental dividends in the future. Forward-looking statements are statements that are not historical statements and can often be identified by words such as “will,” “believe,” “expect” and similar expressions and variations or negatives of these words. These statements are based on management’s current expectations, assumptions and beliefs. They are not guarantees of future results and are subject to numerous risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statement. These risks include risks related to: changes in the markets in which Capital Southwest invests; changes in the financial, capital, and lending markets; changes in the interest rate environment and its impact on our business and our portfolio companies; regulatory changes; tax treatment; our ability to operate the SBIC Subsidiaries as small business investment companies; the uncertainty associated with the imposition of tariffs and trade barriers and changes in trade policy and its impact on our portfolio companies and our financial condition; the impact of geopolitical conditions on our portfolio companies and opportunities available to us; an economic downturn or recession and its impact on the ability of our portfolio companies to operate and the investment opportunities available to us; the impact of supply chain constraints on our portfolio companies; and the elevated levels of inflation and its impact on our portfolio companies and the industries in which we invests.

Readers should not place undue reliance on any forward-looking statements and are encouraged to review Capital Southwest’s Annual Report on Form 10-K for the year ended March 31, 2026 and any subsequent filings with the SEC, including the “Risk Factors” sections therein, for a more complete discussion of the risks and other factors that could affect any forward-looking statements. Except as required by the federal securities laws, Capital Southwest does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.

Investor Relations Contact:

Michael S. Sarner, President and Chief Executive Officer
214-884-3829

CAPITAL SOUTHWEST CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES
(In thousands, except shares and per share data)
		September 30,				March 31,
			2026				2026
		(Unaudited)
Assets
Investments at fair value:
Non-control/Non-affiliate investments (Cost: $1,961,915 and $1,689,152, respectively)		$	1,951,314			$	1,682,425
Affiliate investments (Cost: $371,122 and $338,124, respectively)			359,192				340,760
Control investments (Cost: $126,051 and $92,208, respectively)			99,623				74,261
Total investments (Cost: $2,459,088 and $2,119,485, respectively)			2,410,129				2,097,446
Cash and cash equivalents			47,977				29,045
Restricted cash			4,480				400
Receivables:
Dividends and interest			38,749				31,678
Escrow			613				612
Other			5,818				2,190
Income tax receivable			279				717
Debt issuance costs (net of accumulated amortization of $15,637 and $13,172, respectively)			8,723				6,870
Other assets			7,974				8,560
Total assets		$	2,524,742			$	2,177,518
Liabilities
SBA Debentures (net of $7,336 and $5,333, respectively, of unamortized debt issuance costs)		$	281,664			$	217,667
2029 Convertible Notes (net of $4,674 and $5,413, respectively, of unamortized debt issuance costs)			225,326				224,587
September 2030 Notes (net of $5,355 and $6,029, respectively, of unamortized debt issuance costs)			344,645				343,971
September 2031 Notes (net of $7,883 and $0, respectively, of unamortized debt issuance costs)			337,866				—
Credit Facilities			195,000				345,000
Other liabilities			19,743				21,629
Accrued restoration plan liability			519				529
Income tax payable			1,757				636
Deferred tax liability			11,792				12,507
Total liabilities			1,418,312				1,166,526
Commitments and contingencies (Note 12)
Net Assets
Common stock, $0.25 par value: authorized, 135,000,000 shares at September 30, 2026 and 75,000,000 shares at March 31, 2026; issued, 66,491,300 shares at September 30, 2026 and 60,577,181 shares at March 31, 2026			16,623				15,144
Additional paid-in capital			1,203,681				1,074,854
Total distributable (loss) earnings			(113,874	)			(79,006	)
Total net assets			1,106,430				1,010,992
Total liabilities and net assets		$	2,524,742			$	2,177,518
Net asset value per share (66,491,300 shares outstanding at September 30, 2026 and 60,577,181 shares outstanding at March 31, 2026)		$	16.64			$	16.69

CAPITAL SOUTHWEST CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(In thousands, except shares and per share data)
		Three Months Ended								Six Months Ended
		September 30,								September 30,
			2026				2025				2026				2025
Investment income:
Interest income:
Non-control/Non-affiliate investments		$	47,216			$	40,746			$	89,613			$	81,984
Affiliate investments			7,445				6,831				14,640				12,087
Control investments			443				681				1,317				1,302
Payment-in-kind interest income:
Non-control/Non-affiliate investments			3,395				1,673				7,352				3,749
Affiliate investments			1,051				912				1,924				1,865
Control investments			535				209				617				440
Dividend income:
Non-control/Non-affiliate investments			608				52				775				1,660
Affiliate investments			345				2,690				1,556				4,735
Control investments			1,039				—				1,297				24
Fee income:
Non-control/Non-affiliate investments			3,883				1,740				7,191				3,136
Affiliate investments			473				770				870				959
Control investments			29				23				56				46
Other income			696				618				998				905
Total investment income			67,158				56,945				128,206				112,892
Operating expenses:
Compensation			3,240				2,631				5,939				6,587
Share-based compensation			1,937				1,270				3,385				2,413
Interest			20,981				16,020				39,480				31,284
Professional fees			1,963				1,341				3,427				2,551
General and administrative			1,871				1,666				3,841				3,323
Total operating expenses			29,992				22,928				56,072				46,158
Income before taxes			37,166				34,017				72,134				66,734
Federal income, excise and other taxes			678				1,149				1,121				2,248
Deferred taxes			196				884				(958	)			613
Total income tax provision			874				2,033				163				2,861
Net investment income		$	36,292			$	31,984			$	71,971			$	63,873
Realized gain (loss)
Non-control/Non-affiliate investments		$	3,734			$	3,485			$	4,067			$	21,331
Affiliate investments			3				(7,652	)			71				(3,565	)
Income tax provision			(588	)			(759	)			(1,547	)			(6,988	)
Total net realized gain (loss) on investments, net of tax			3,149				(4,926	)			2,591				10,778
Net unrealized (depreciation) appreciation on investments
Non-control/Non-affiliate investments			(7,891	)			(12,146	)			(3,873	)			(34,208	)
Affiliate investments			(3,120	)			10,757				(14,566	)			11,815
Control investments			(5,650	)			1,010				(8,481	)			(2,166	)
Income tax benefit (provision)			66				(1,058	)			(65	)			2,530
Total net unrealized (depreciation) appreciation on investments, net of tax			(16,595	)			(1,437	)			(26,985	)			(22,029	)
Net realized and unrealized (losses) gains on investments			(13,446	)			(6,363	)			(24,394	)			(11,251	)
Realized loss on extinguishment of debt			(1,410	)			—				(1,410	)			—
Realized loss on disposal of fixed assets			—				(2	)			—				(2	)
Net increase in net assets from operations		$	21,436			$	25,619			$	46,167			$	52,620
Pre-tax net investment income per share – basic		$	0.58			$	0.61			$	1.14			$	1.21
Net investment income per share – basic		$	0.56			$	0.57			$	1.14			$	1.16
Net increase in net assets from operations – basic		$	0.33			$	0.46			$	0.73			$	0.95
Net increase in net assets from operations – diluted		$	0.33			$	0.44			$	0.73			$	0.92
Weighted average common shares outstanding – basic			63,648,525				55,544,095				62,401,982				54,536,084
Weighted average common shares outstanding – diluted			73,036,538				64,830,413				71,777,799				63,809,345

SOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseases, today announced senior management will present and participate in one-on-one meetings at the following upcoming investor conferences in November:

Guggenheim 3^rd Annual Healthcare Innovation Conference
Date: Tuesday, November 10
Fireside chat: 2:00 PM ET

UBS Global Biopharma Conference
Date: Monday, November 16
Fireside chat: 12:00 PM GMT

2026 Jefferies Global Healthcare Conference in London
Date: Tuesday, November 17

Webcasts for the fireside chats will be available through the Events and Presentations section of Assembly Bio’s website at: https://investor.assemblybio.com/events-presentations. Replays will be accessible following the events.

About Assembly Biosciences
Assembly Biosciences is a biotechnology company developing innovative small-molecule therapeutics aimed at advancing the treatment paradigm of serious viral and liver diseases and improving the lives of patients worldwide. Led by an accomplished leadership team in antiviral and liver disease drug development, Assembly Bio is committed to improving outcomes for people living with the chronic impacts of herpesviruses, hepatitis delta virus (HDV) infections, cholestatic liver diseases and hepatitis B virus (HBV). For more information, visit assemblybio.com.

Forward-Looking Statements
The information in this press release contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to materially differ. These risks and uncertainties include: Assembly Bio’s ability to realize the potential benefits of its collaboration with Gilead, including all financial aspects of the collaboration and equity investments; Assembly Bio’s ability to initiate and complete clinical studies involving its therapeutic product candidates, including studies contemplated by Assembly Bio’s collaboration with Gilead, including studies conducted by Gilead, in the currently anticipated timeframes or at all; safety and efficacy data from clinical or nonclinical studies may not warrant further development of product candidates; clinical and nonclinical data may not differentiate product candidates from other companies’ candidates; Assembly Bio’s ability to maintain financial resources and secure additional funding necessary to continue its research activities, clinical studies, and other business operations; potential effects of changes in government regulation; results of nonclinical studies may not be representative of disease behavior in a clinical setting and may not be predictive of the outcomes of clinical studies; and other risks identified from time to time in Assembly Bio’s reports filed with the U.S. Securities and Exchange Commission (the SEC). You are urged to consider statements that include the words may, will, would, could, should, might, believes, hopes, estimates, projects, potential, expects, plans, anticipates, intends, continues, forecast, designed, goal or the negative of those words or other comparable words to be uncertain and forward-looking. Assembly Bio intends such forward-looking statements to be covered by the safe harbor provisions contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. More information about Assembly Bio’s risks and uncertainties are more fully detailed under the heading “Risk Factors” in Assembly Bio’s filings with the SEC, including its most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Except as required by law, Assembly Bio assumes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

Contacts:
Investors:
Patrick Till
Meru Advisors
(484) 788-8560
investor_relations@assemblybio.com

Media:
Mike Beyer
Sam Brown LLC
(312) 961-2502
ASMBMedia@sambrown.com

WAYNE, Pa., Nov. 02, 2026 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced that management will participate in the following investor conferences:

Guggenheim Healthcare Innovation Conference
Fireside Chat
November 9, 2026 at 8:30am ET

Stifel 2026 Healthcare Conference
Fireside Chat
November 10, 2026 at 2:00pm ET

Live webcasts and replays, when available, can be found under “News / Events” in the Investors section of the Avalo Therapeutics website at https://ir.avalotx.com. The archived webcast will be available for replay for at least 30 days.

About Avalo Therapeutics

Avalo Therapeutics is a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases. Avalo is advancing its lead anti-IL-1β monoclonal antibody (mAb) drug candidate, abdakibart, into a phase 3 registrational program in hidradenitis suppurativa (HS), a chronic inflammatory skin condition that affects an estimated 1-4% of the population globally. Avalo is pursuing additional development opportunities in IL-1β driven indications. Avalo is also developing AVTX-010, a long-acting next-generation anti-IL-1β mAb. For more information about Avalo, please visit www.avalotx.com.

For media and investor inquiries
Jonathan Neely
VP, Head of Investor Relations
jneely@avalotx.com 

or

Meru Advisors
Lauren Glaser
lglaser@meruadvisors.com 

LOS ANGELES, Nov. 02, 2026 (GLOBE NEWSWIRE) — EVgo Inc. (“EVgo”) (NASDAQ: EVGO), one of the nation’s largest providers of public fast charging infrastructure for electric vehicles, today announced that its Board of Directors (“Board”) received an unsolicited and non-binding proposal (“Proposal”) from LS Power Equity Advisors, LLC and certain of its affiliates (collectively, “LS Power”) to acquire all of the outstanding shares of EVgo’s Class A common stock not currently owned by LS Power for cash consideration of $2.00 per share. LS Power currently holds approximately 56% of the combined voting power of EVgo’s outstanding common stock. A copy of the Proposal is available as an exhibit to EVgo’s Current Report on Form 8-K, which will be filed today with the Securities and Exchange Commission.

The Board has established a special committee composed of independent and disinterested directors to review and evaluate the Proposal. The special committee is authorized to retain independent advisors, including independent legal and financial advisors, to assist it in its work. No decisions have been made with respect to EVgo’s response to the Proposal. There can be no assurance that any definitive agreement relating to any proposed transaction will be executed or as to the terms thereof, or that any transaction will be approved or consummated. EVgo does not intend to comment further or disclose any developments regarding the Proposal unless and until it deems further disclosure is appropriate or required. EVgo’s shareholders do not need to take any action at this time.

About EVgo

EVgo Inc. (NASDAQ: EVGO) is one of the nation’s largest and most highly utilized public fast charging providers. With more than 1,200 fast charging locations across 47 states, EVgo makes charging part of everyday life by partnering with leading businesses including retailers, grocery stores, rideshare operators and autonomous vehicle companies. EVgo is scaling nationwide, strategically deploying high-power chargers, including EVgo Superchargers, across the U.S. At its dedicated Innovation Lab, EVgo is developing its next-generation chargers, performing extensive interoperability testing and collaborating with leading automakers and industry partners to advance the EV charging industry and deliver a seamless charging experience. 

Caution Concerning Forward Looking Statements

This press release contains forward-looking statements that are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to certain risks, uncertainties, or other factors that are difficult to predict and could cause actual events or results to differ materially from those indicated in any such statements due to a number of risks and uncertainties. Those risks and uncertainties that could cause the actual events or results to differ from expectations contemplated by forward-looking statements include, among other things: risks and uncertainties relating to the unsolicited and non-binding take private proposal received from LS Power to acquire all of the outstanding shares of EVgo’s Class A common stock not currently owned by LS Power, including the possibility that any such transaction may not be pursued, approved, or consummated on the proposed terms, within any anticipated timeframe, or at all; the special committee’s review and evaluation of the Proposal; the effect of the announcement of the Proposal on EVgo’s business, stock price and relationships with customers, partners and employees; the risk of litigation relating to the Proposal or any proposed transaction; and those described under the heading “Risk Factors” and elsewhere in our most recent Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K filed with the Securities and Exchange Commission. Forward-looking statements are based on EVgo’s management’s current assumptions, expectations, and beliefs and are not guarantees of future performance. In light of these risks, uncertainties, and assumptions, actual results could differ materially and adversely from those anticipated or implied by the forward-looking statements. You should not rely on forward-looking statements as predictors of future results. Any forward-looking statements in this release are based on the limited information currently available to EVgo as of the date hereof, which is subject to change, and EVgo does not undertake any obligation to update these statements, even if new information becomes available in the future.

CONTACT: Contacts

For Investors:

investors@evgo.com

For Media:

press@evgo.com

Interactive website brings together live prediction market odds, congressional control indicators and competitive races in one destination

LAS VEGAS, Nevada, Nov. 02, 2026 (GLOBE NEWSWIRE) — High Roller Technologies, Inc. (“High Roller” or the “Company”) (NYSE: ROLR), an online gaming and prediction markets company, today announced today highlighted its election tracking website, elections.rolr.com, providing an interactive view of prediction market expectations for the 2026 U.S. midterm elections.

As Americans head to the polls, the ROLR^™ election dashboard offers a convenient destination to follow shifting market odds for control of the U.S. House of Representatives and Senate, explore individual congressional and gubernatorial races, and identify the closest contests and biggest changes in market expectations.

“Election Day brings an enormous amount of information, and people want an intuitive way to understand what’s changing and which races matter,” said Seth Young, Chief Executive Officer of High Roller Technologies. “Our election dashboard brings the prediction market perspective into one accessible experience, from the national balance of power to individual races. It’s also a compelling introduction to ROLR, helping people discover the markets behind the numbers and follow the outcomes that interest them.”

The website’s features include:

• Balance-of-power indicators: Visual gauges display market odds for House and Senate control, alongside market-derived estimates of Senate seats, the House popular-vote margin and net gubernatorial pickups.
• Interactive election maps: Visitors can explore tracked Senate, House and gubernatorial contests by state and select individual races for additional detail.
• Closest races and biggest movers: Dedicated sections highlight competitive contests and the largest changes in race odds over the preceding 24 hours, where historical data are available.
• Search, filters and watchlists: Users can search by state, district or market, filter by election category and save markets to a watchlist.
• Price histories and market access: Charts show how contract prices have changed, with links to the corresponding markets on ROLR for eligible customers.

The dashboard updates as new quotes arrive from ROLR, allowing visitors to follow how market expectations evolve throughout Election Day and as the electoral picture develops.

The displayed odds and estimates reflect prediction market prices and the dashboard’s calculations; they are not official election results or guarantees of an outcome. Data are provided for informational purposes and may be delayed or incorrect.

Explore the election dashboard at elections.rolr.com. To learn more about ROLR and available prediction markets, visit rolr.com.

About High Roller Technologies, Inc.

High Roller Technologies, Inc. (NYSE: ROLR) is a publicly traded online gaming and prediction markets company, known for its innovative casino brands High Roller and Fruta, and its prediction markets brand, ROLR. The Company delivers cutting-edge real-money consumer facing products that are intuitive and user-friendly. With a diverse portfolio of over 6,000 premium online casino games from more than 90 leading game providers, High Roller Technologies offers an immersive and engaging gaming experience in the rapidly expanding multi-billion-dollar iGaming industry. As an award-winning operator, High Roller Technologies continues to redefine the future of market engagement through innovation, performance, and a commitment to excellence.

For more information, please visit the Company’s investor relations website and follow High Roller Technologies on X, Facebook, and LinkedIn.

Forward-Looking Statements

Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions, the commercial launch and growth of the ROLR^™ prediction markets platform. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, our limited operating history in the prediction markets business; risks related to platform stability, scalability and technical performance, our ability to attract, convert and retain platform users and to generate revenue from the platform in the anticipated timeline or at all, the effectiveness of and cost of our marketing and customer-acquisition efforts and the performance of our marketing and distribution partners; our reliance on third parties, including Crypto.com | Derivatives North America, Crypto.com FCM and mrkts.com, and the continuation of our guarantee, license and development agreements; our ability to maintain the registration of ROLR US LLC as a guaranteed introducing broker and its membership in the National Futures Association, the evolving regulatory environment applicable to prediction markets and event-based contracts, and general market and economic conditions and such factors as discussed throughout Part I, Item 1A. Risk Factors and Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K for the year ended December 31, 2025, Part I. Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations and Part II, Item 1A. Risk Factors, of our quarterly report on Form 10-Q/A for the quarter ended June 30, 2026 and in our other filings with the Securities and Exchange Commission. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Contact
Investor Relations
ir@highroller.com
800-460-1039

The new on-demand hiring experience connects people and businesses with skilled professionals who are online and ready to work now, on Upwork or from inside the AI tools they’re already using

PALO ALTO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) — Upwork Inc. (NASDAQ: UPWK), the world’s human and AI-powered work marketplace, today announced the public beta of Upwork Now. Clients can see available freelancers, review a shortlist and hire in minutes, while freelancers can connect with clients who are ready to hire and get work started.

With Upwork Now, a founder preparing to launch a website can find a developer to fix a last-minute issue. A marketing team facing a deadline can connect with a designer ready to help. Someone deep in a build with AI can bring in an expert to review their code before it ships. And through the Upwork MCP server, clients can do it without ever leaving the AI tools where their work began.

AI is making it easier to get started on projects and move work forward quickly. The ability to hire the right expert needs to keep pace. In an Upwork survey, 57% of clients said they would prefer to hire in a day or less.¹ Upwork Now was built for that need, to help clients bring in human expertise at the speed of AI.

In early testing, clients who took advantage of Upwork Now typically hired in under 30 minutes, with the fastest hiring in under 10. When those clients reached out to freelancers, the typical response came in about five minutes.²

“The faster people work with AI, the more it matters that the right expert is there the moment a task needs human judgment, creativity, or careful review,” said Peter Sanborn, Chief Business Officer at Upwork. “Upwork Now unlocks a new on-demand way for people and AI to work together. Whether you’re on Upwork or deep in an AI tool, you can bring in highly skilled talent who can start right away, and freelancers get a way to turn their availability into work when they’re ready to take it on.”

For clients: When posting a job on Upwork.com, clients can turn on “Hire Now” to reach skilled professionals who are online and ready to start. Responses appear in a live feed and a real-time shortlist helps them review qualified candidates. Upwork Now will be coming soon to freelancer search.

For freelancers: Freelancers can turn on “Work Now” from their homepage or profile to signal they’re ready to start right away. They can then see which clients are actively online and hiring now while they search for jobs, and respond to those who need help immediately.

Inside AI tools: Clients can use Upwork Now from inside their favorite AI tools by connecting them to Upwork. Once connected, their AI tool can use the context of the work already underway to find freelancers who can start now. In the coming weeks, freelancers will also be able to manage their “Work Now” availability from their AI tools.

Upwork Now is the latest step in making human expertise available the moment work needs it, wherever that work begins. Earlier this year, Upwork launched its Model Context Protocol (MCP) server, enabling customers to hire, win jobs, and manage work inside any compatible AI tool. Where the MCP server lets agents connect with the Upwork Marketplace, Upwork Now lets them connect with human expertise on demand. Every action, whether taken by a person or an agent, is built on the same trust and safety infrastructure that backs Upwork engagements today.

Upwork Now is available as a public beta to all clients and freelancers on Upwork at no additional cost. To get started, visit Upwork.com or connect Upwork to your favorite AI tool at www.upwork.com/ai/plugins.

^{____________________________
1} Based on an Upwork survey of 150 U.S. based clients that hire on Upwork conducted April 2026.
² Based on Upwork internal data from October 7th, 2026 to October 26th, 2026 for clients who turned on Upwork Now and hired within one hour of doing so. “Work started” refers to contract start. Response time measures the median time between a client’s outreach and a freelancer’s first reply.

About Upwork

Upwork Inc.’s (Nasdaq: UPWK) family of companies connects businesses with global, AI-enabled talent across every contingent work type including freelance, agency, fractional, and payrolled. This portfolio includes the Upwork Marketplace, which connects businesses with on-demand access to highly skilled talent across the globe, and Lifted, which provides a purpose-built solution for enterprise organizations to source, contract, manage, and pay talent across the full spectrum of contingent work. From Fortune 100 enterprises to entrepreneurs, businesses rely on Upwork Inc. to find and hire expert talent, leverage AI-powered work solutions, and drive business transformation. With access to professionals spanning more than 10,000 skills across AI & machine learning, software development, sales & marketing, customer support, finance & accounting, and more, the Upwork family of companies enables businesses of all sizes to scale, innovate, and transform their workforces for the age of AI and beyond.

Since its founding, Upwork Inc. has facilitated more than $30 billion in total transactions and services as it fulfills its purpose to create opportunity in every era of work. Learn more about the Upwork Marketplace at upwork.com and follow on LinkedIn, Facebook, Instagram, TikTok, and X; and learn more about Lifted at go-lifted.com and follow on LinkedIn.

Safe Harbor

This press release of Upwork Inc. (together with its wholly owned subsidiaries, the “Company,” “we,” “us,” or “our”) contains “forward-looking” statements within the meaning of the federal securities laws. Forward-looking statements include all statements other than statements of historical fact, including any statements regarding information or predictions concerning the future of our business or strategy, future products, features, or functionality, future market opportunity, anticipated events and trends, technological and market trends, the expected impact and timing of strategic initiatives, and other future conditions.

We have based these forward-looking statements largely on our current expectations and projections as of the date hereof. As such, they are subject to inherent uncertainties, known and unknown risks, and changes in circumstances that are difficult to predict and in many cases outside our control, and you should not place undue reliance on such forward-looking statements. Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. We make no representation that the plans, intentions, expectations, or results disclosed in these forward-looking statements will be achieved or that future events and circumstances will occur, and actual results or events may differ materially and adversely from our expectations. The forward-looking statements are made as of the date hereof, and we do not undertake, and expressly disclaim, any obligation to update or revise any forward-looking statements, conform these statements to actual results, or make changes in our expectations, except as required by law. Additional information regarding the risks and uncertainties that could cause actual results to differ materially from our expectations is included under the caption “Risk Factors” in our Quarterly Report on Form 10-Q for the three months ended September 30, 2026, when filed, and in our other SEC filings, which are available on our Investor Relations website at investors.upwork.com and on the SEC’s website at www.sec.gov.

Media Contact:
press@upwork.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/02effbea-4241-469e-b6ce-0f048034d498

ALK (ALKB:DC / Nasdaq Copenhagen: ALK B): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following transactions by managerial staff as set forth in the attached announcement.

ALK-Abelló A/S

For further information please contact:

Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525

Media: Maiken Riise Andersen, tel. +45 5054 1434

Attachment

• Company release_18_26UK_021126_ Managers transactions

Collaboration combines Omniapart’s risk management and compliance expertise with U.S.-based professional services resources, creating opportunities for future AI-enabled solutions.

ROME, Italy, and CLARKSBURG, Maryland, Nov. 02, 2026 (GLOBE NEWSWIRE) — Omniapart S.r.l., an Italy-based provider of risk management and compliance consulting and proprietary agentic AI solutions, and Reliability Workplace Solutions, LLC (RWS), a company within publicly traded Reliability, Inc. (OTC: RLBY), today announced a strategic services agreement to support the delivery and expansion of specialized professional services in the United States and international markets.

Under the Master Services Agreement, executed October 29, 2026, RWS will source and provide qualified professionals to support Omniapart’s client engagements in risk assessment, auditing, compliance, gap analysis and related professional services.

“This agreement represents an important step in strengthening Omniapart’s presence in the United States and expanding our ability to serve multinational clients,” said Francesco Cipullo, Chief Executive Officer of Omniapart. “By combining our specialized consulting and technology expertise with the professional resources available through Reliability Workplace Solutions, we are building a stronger foundation for international growth.”

The collaboration builds upon a professional relationship dating to 2018–2019, when Omniapart partnered with Mark Speck through his former consulting firm, Specktrum, LLC, on U.S.-based auditing, compliance and professional services initiatives. Speck now serves as President and Chief Financial Officer of Reliability, Inc.

“We are pleased to build upon our longstanding relationship with Francesco and Omniapart,” said Mark Speck, President and Chief Financial Officer of Reliability, Inc. (OTC: RLBY). “This collaboration advances our strategy to diversify Reliability’s business, expand our professional services capabilities and establish relationships with multinational clients. We see meaningful opportunities to leverage our workforce expertise in support of specialized audit and consulting engagements.”

Expanding International Professional Services

Under the agreement, RWS will leverage its professional services capabilities and access to qualified U.S.-based talent to support Omniapart’s consulting and project delivery requirements.

Initial services are expected to include risk assessments, operational audits, compliance reviews, gap analyses and advisory support related to certification and regulatory requirements.

The collaboration is designed to serve multinational organizations with operations spanning the United States, Europe and Australia, providing access to specialized expertise and scalable professional resources.

“Thanks to the agreement with Reliability Workplace Solutions, we can strengthen our presence in the United States with high-caliber professionals and grow in our target market,” said Michele Marchisano, Chief Operating Officer of Omniapart.

Initial market opportunities include healthcare, energy, data center infrastructure and other industries where regulatory compliance, operational risk and quality assurance are critical business priorities.

“Our focus is on identifying and deploying qualified professionals who can meet the specialized requirements of Omniapart’s multinational clients,” said John Pickeral, Executive Vice President and Chief Operating Officer of Reliability, Inc. “We believe our ability to deliver responsive, scalable resources will be instrumental in supporting these engagements.”

Combining Professional Expertise with Emerging AI Capabilities

Beyond traditional consulting services, the companies intend to explore potential opportunities to collaborate on the development, adaptation and deployment of Omniapart’s proprietary AI solutions, leveraging RWS’s access to specialized professional expertise.

Omniapart has developed AI-enabled compliance and risk management technologies, including Tony, its semantic agent originally developed to support GDPR compliance.

Central to Omniapart’s technology strategy is its Human Check approach, which emphasizes the importance of professional expertise, validation and continuing human oversight in AI-supported business processes.

“An AI agent is only as effective as the expertise of the people who train it,” said Cipullo. “Since 2019, with Tony, our semantic agent for GDPR compliance, we have applied the Human Check principle: people train AI agents and maintain oversight over time. Synthetic data can imitate a process, but only professional experience can identify what does not work.”

“As this relationship evolves, we see potential to combine our professional services capabilities with Omniapart’s AI technologies to address emerging client needs,” added Speck.

Omniapart also publishes Omniapart AI Blueprint, an English-language publication addressing emerging developments in AI governance, compliance and risk management.

Supporting International Growth

The collaboration supports Omniapart’s strategy to expand its presence in North America while serving multinational organizations operating across Europe, the United States and Australia. Both companies anticipate that the relationship will provide a foundation for additional professional services engagements as market opportunities develop.

The companies also see growing demand for specialized risk management, compliance and AI governance services as organizations navigate increasingly complex regulatory requirements and the adoption of artificial intelligence.

About Omniapart

Founded in 2005 and headquartered in Rome, Italy, Omniapart provides consulting and technology solutions in risk management, compliance, auditing and certification, cybersecurity, training, sustainability and digital infrastructure.

Since 2019, the company has developed proprietary AI agents and related technologies based on an approach that integrates professional expertise, process knowledge and continuous human oversight.

Website: https://omniapart.com/

About Reliability, Inc.

Reliability, Inc. (OTC: RLBY) is a publicly traded company providing specialized workforce solutions and professional services through its operating subsidiaries, The Maslow Media Group, Inc. and Reliability Workplace Solutions, LLC.

Founded in 1988, The Maslow Media Group provides staffing, recruiting, employer-of-record services and video production solutions, with an established presence in the media, broadcast and entertainment industries and services extending across a broad range of commercial sectors.

Reliability Workplace Solutions operates through its Professional Services and Healthcare IT divisions, providing access to qualified professionals in auditing, compliance, risk management, technology, healthcare and other specialized business functions.

Together, these businesses support Reliability’s strategy to expand its professional services capabilities, diversify its client base and pursue growth opportunities across domestic and international markets.

Website: https://rlby.com/

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable federal securities laws. These statements include, but are not limited to, expectations regarding the strategic relationship between Reliability Workplace Solutions, LLC and Omniapart S.r.l., anticipated professional services opportunities, international market expansion, potential future client engagements, and the exploration of AI-enabled business solutions.

Forward-looking statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include the ability to secure and execute future client engagements, recruit and retain qualified professionals, successfully expand into new markets, develop and maintain strategic business relationships, and respond to competitive, economic and regulatory conditions, as well as other risks described in Reliability Incorporated’s filings with the Securities and Exchange Commission.

Reliability Incorporated undertakes no obligation to update or revise any forward-looking statements, except as required by applicable law.

Media Contacts
Omniapart S.r.l.
info@omniapart.com
Reliability Workplace Solutions, LLC
InvestorRelations@rlby.com